Previous Close | 61.76 |
Open | 61.76 |
Bid | 55.25 |
Ask | 58.40 |
Strike | 50.00 |
Expire Date | 2025-01-17 |
Day's Range | 61.76 - 61.76 |
Contract Range | N/A |
Volume | |
Open Interest | 20 |
Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range. Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but Abbott stock slipped.